UCB's Cimzia(TM) (certolizumab pegol) approved by Health Canada for adult patients suffering from moderate to severe rheumatoid arthritis

    TORONTO, Sept. 1 /CNW/ - To view this Social Media Release, please enter
the following address in your web browser.


For further information:

For further information: For a complete listing of social media releases
available through CNW Group, please visit our calendar at

Organization Profile

CNW Enriched News Releases

More on this organization

UCB Canada Inc.

More on this organization

Custom Packages

Browse our custom packages or build your own to meet your unique communications needs.

Start today.

CNW Membership

Fill out a CNW membership form or contact us at 1 (877) 269-7890

Learn about CNW services

Request more information about CNW products and services or call us at 1 (877) 269-7890